Nov 3, 2017

Twitter blames “human error” for temporarily deactivating @realdonaldtrump

Twitter signage is draped on the facade of the New York Stock Exchange. Photo: Mark Lennihan / AP

Twitter released a statement Thursday evening saying an employee had "inadvertently deactivated" President Trump's personal twitter account. The removal of Trump's account caused an immediate reaction among Twitter users, until the account reappeared minutes later.

"Earlier today @realdonaldtrump's account was inadvertently deactivated due to human error by a Twitter employee. The account was down for 11 minutes, and has since been restored. We are continuing to investigate and are taking steps to prevent this from happening again."

Update: Twitter said its preliminary investigation shows Trump's account was deactivated by a customer support representative on their last day of work at Twitter.

Go deeper

GOP sees more hurdles for Trump as coronavirus crisis drags on

Photo: Alex Wong/Getty Images

Republicans are increasingly concerned not only about President Trump’s daily briefings but also his broader plan to ease the nation out of the virus crisis and back to work. This concern is acute — and spreading. 

Why it matters: Trump can easily address the briefing worries by doing fewer, but the lackluster bounce-back planning is what worries Republicans most. 

Pandemic forces startups to shift gears

Illustration: Eniola Odetunde/Axios

Spaces CEO Brad Herman had an early warning about COVID-19 because his startup supplies VR attractions to a number of theme parks in China. Realizing that the business he spent the last few years building was going to evaporate, Herman quickly found a new way to apply his team's know-how: helping companies host Zoom teleconferences in VR.

Why it matters: Many startups are rethinking the viability of their core businesses in the wake of the coronavirus. Spaces' move is one of many such pivots likely to crop up in the coming months.

International coronavirus treatment trial uses AI to speed results

Hydroxychloroquine is one of the drugs that will be included in the trial. Photo: John Philips/Getty Images

The first hospital network in the U.S. has joined an international clinical trial using artificial intelligence to help determine which treatments for patients with the novel coronavirus are most effective on an on-going basis.

Why it matters: In the midst of a pandemic, scientists face dueling needs: to find treatments quickly and to ensure they are safe and effective. By using this new type of adaptive platform, doctors hope to collect clinical data that will help more quickly determine what actually works.